Europe Cell Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others), and Country.

No. of Pages: 165    |    Report Code: TIPRE00019052    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Cell Therapy Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Cell Therapy Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Cell Therapy Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in Demand for Novel Therapeutics to Treat Chronic Diseases Like Cancer
5.2 Market Opportunities
  • 5.2.1 Research and Development Funding
5.3 Future Trends
  • 5.3.1 Technological Advancement
5.4 Impact of Drivers and Restraints

6. Europe Cell Therapy Market Regional Analysis

6.1 Europe Cell Therapy Market Overview
6.2 Europe Cell Therapy Market Revenue 2017-2027 (US$ Million)
6.3 Europe Cell Therapy Market Forecast Analysis

7. Europe Cell Therapy Market Analysis – by Therapy Type

7.1 Allogeneic
  • 7.1.1 Overview
  • 7.1.2 Allogeneic: Europe Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Autologous
  • 7.2.1 Overview
  • 7.2.2 Autologous: Europe Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Cell Therapy Market Analysis – by Product

8.1 Consumables
  • 8.1.1 Overview
  • 8.1.2 Consumables: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Equipment
  • 8.2.1 Overview
  • 8.2.2 Equipment: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Systems and Software
  • 8.3.1 Overview
  • 8.3.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Cell Therapy Market Analysis – by Technology

9.1 Viral Vector Technology
  • 9.1.1 Overview
  • 9.1.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Genome Editing Technology
  • 9.2.1 Overview
  • 9.2.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Somatic Cell Technology
  • 9.3.1 Overview
  • 9.3.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cell Immortalization Technology
  • 9.4.1 Overview
  • 9.4.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Cell Plasticity Technology
  • 9.5.1 Overview
  • 9.5.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Three-dimensional Technology
  • 9.6.1 Overview
  • 9.6.2 Systems and Software: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Cell Therapy Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Cell Therapy Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Europe Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 UK: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.1.2 UK: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.1.3 UK: Europe Cell Therapy Market Breakdown, by Technology
  • 10.1.1.2 Germany: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.2.2 Germany: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.2.3 Germany: Europe Cell Therapy Market Breakdown, by Technology
  • 10.1.1.3 France: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 France: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.3.2 France: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.3.3 France: Europe Cell Therapy Market Breakdown, by Technology
  • 10.1.1.4 Russia: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.4.2 Russia: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.4.3 Russia: Europe Cell Therapy Market Breakdown, by Technology
  • 10.1.1.5 Italy: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.5.2 Italy: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.5.3 Italy: Europe Cell Therapy Market Breakdown, by Technology
  • 10.1.1.6 Rest of Europe: Europe Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Cell Therapy Market Breakdown, by Therapy Type
    • 10.1.1.6.2 Rest of Europe: Europe Cell Therapy Market Breakdown, by Product
    • 10.1.1.6.3 Rest of Europe: Europe Cell Therapy Market Breakdown, by Technology

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Cell Therapy Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Vericel Corporation
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 MEDIPOST
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 NuVasive, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Mesoblast Limited
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Smith & Nephew
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Bristol-Myers Squibb Company
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cells for Cells
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Stemedica Cell Technologies, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Cell Therapy Market

  1. Vericel Corporation
  2. MEDIPOST
  3. NuVasive, Inc.
  4. Mesoblast Limited
  5. Smith & Nephew
  6. Bristol-Myers Squibb Company
  7. Cells for Cells
  8. Stemedica Cell Technologies, Inc.
europe-cell-therapy-market